GoMe
Personalized Treatment Platform for Childhood Obesity
Company Overview
Snapshot
Founded in September 2019 by Dan Avramov and Ran Gilhar, GoMe operates with 1–10 employees. The company ceased operations in December 2020.
Business overview
GoMe is developing a digitized, one-stop platform for customizing childhood obesity treatments and monitoring patients, including children and their families. The company's core technology is an automated software treatment platform featuring an advanced algorithm that creates personalized therapeutic roadmaps. This system includes a dashboard for insights, feedback, recommendations, and alerts. GoMe serves the digital healthcare and digital therapeutics sectors, providing user-friendly interfaces for therapists, parents, and children, with the child interface incorporating gamification and customized content to inspire habit change.
Log in to access full profile ›Company Intelligence Q&A
- What is GoMe's primary focus?
- GoMe focuses on developing a personalized treatment platform for childhood obesity, aiming to digitize and customize therapeutic approaches for children and their families.
- When was GoMe founded?
- GoMe was founded in September 2019.
- Who are the founders of GoMe?
- GoMe was co-founded by Dan Avramov, who serves as CTO, and Ran Gilhar, who holds the roles of COO and CFO.
- What is the status of GoMe?
- GoMe is currently non-active, having ceased operations in December 2020.
- What technology does GoMe utilize?
- GoMe utilizes an automated software treatment platform with an advanced algorithm to build personalized therapeutic roadmaps. The system includes a dashboard for insights, feedback, recommendations, and alerts.